Specialties

Study indicates that giving 1,000 patients pioglitazone (Actos) would avoid 21 first heart attacks, strokes or deaths over 3 years.

Researchers have found that a long-suspected molecule helps cause diabetic retinopathy, one of the leading causes of vision loss in the United States and the world.

Bone marrow cells that produced insulin adversely affected nerve cells or neurons.

New study suggests an oversupply of a simple blood sugar could be a major cause of erectile dysfunction in diabetic men.

People in their 70s have a more than 60 percent higher risk of fractures if they also have type 2 diabetes, the most common form of the disease, according to new study findings.

ACE Inhibitors and ARBs Have Same Impact on Proteinuria and BP Reduction in Patients With Diabetic Nephropathy Angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) either alone or in combination appear to have comparable impact in reducing proteinuria and blood pressure in patients with diabetic nephropathy.

An international study led by a Joslin Diabetes Center scientist suggests a new treatment may be effective in reducing vision loss in diabetes patients.

Adolescents with type 1 diabetes in chronically poor metabolic control improve with multisystemic therapy, an intensive, home-based, family-centered psychotherapy.

Testing fasting blood glucose and measuring abdominal obesity is a cost-effective approach to identifying patients taking second-generation antipsychotics with metabolic syndrome.

Nearly one out of every five pediatric patients with type 2 diabetes also has a neurodevelopmental disorder, psychiatric illness or behavioral disorder.